Navigation Links
Perrigo Announces Launch of Generic Version of Elestat®
Date:11/1/2011

ALLEGAN, Mich., Nov. 1, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, PharmaForce/Luitpold Pharmaceuticals, received final approval for Epinastine HCl ophthalmic solution, 0.05%, a generic version of Elestat®. Perrigo will commence shipment of the product immediately.

Elestat® is a sterile ophthalmic solution containing epinastine that is indicated for the prevention of ocular itching associated with allergic conjunctivitis. Estimated annual brand sales for the product prior to generic market formation were $30 million, according to Wolters Kluwer data.

Perrigo's Chairman and CEO Joseph C. Papa stated, "Perrigo is excited to launch another new product in the ophthalmic category, as part of our extended topical strategy. This product is another example of Perrigo's commitment to expand our portfolio and bring new products to market. It further demonstrates our strategy to deliver quality affordable healthcare products."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products and infant formulas, both for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Perrigo Company to Attend the 2011 Annual Meeting of the American College of Allergy, Asthma & Immunology
2. Perrigo Reports Record Quarterly Revenue and Adjusted Earnings and Raises Full Year Adjusted EPS Guidance
3. Perrigo Company Announces Quarterly Dividend
4. Perrigo Expands Infant Formula Distribution in China With Founder Group
5. Perrigo Company Will Release First Quarter Fiscal 2012 Results On October 27, 2011
6. Perrigo Company Confirms FDA Tentative Approval for Clobetasol Propionate Emulsion Foam
7. Perrigo to Host Analyst Day on October 5, 2011 at the TASE, Tel Aviv Stock Exchange in Tel Aviv, Israel
8. Perrigo to Host Analyst Day on September 27, 2011 at the NASDAQ MarketSite in Times Square
9. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
10. Perrigo Company Will Release Fourth Quarter Fiscal 2011 Results on August 16, 2011
11. Watson Enters into Agreement to Acquire Products Related to Perrigos Acquisition of Paddock Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014  Echo Therapeutics, Inc. ... company, today announced that, as it believes that ... needs beyond September 30, 2014, it has suspended ... and operations to conserve its liquidity and capital ... strategic review of Echo,s current financial position, funding ...
(Date:9/23/2014)... Transcatheter Heart Valve 2007 to 2020 - Europe ( ... , UK, Spain ) Summary GBI Research,s report, ... ( Germany , France , ... the transcatheter heart valves market in Europe . The analysis ... key company share data by revenue in 2013 for the following countries: ...
(Date:9/23/2014)... , Sept. 23, 2014 Ultrasound devices ... body in order to diagnose diseases and also ... surgical instruments while performing surgeries. This report studies ... parameters such as product type, technologies, applications and ... market, based on the product type has been ...
Breaking Medicine Technology:Echo Therapeutics Suspends Operations To Conserve Liquidity 2Echo Therapeutics Suspends Operations To Conserve Liquidity 3Echo Therapeutics Suspends Operations To Conserve Liquidity 4Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) 2Ultrasound Devices Market (By Product Type, By Technology and By Application - Obstetrics and Gynecology, Cardiovascular, Abdominal and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019 2Ultrasound Devices Market (By Product Type, By Technology and By Application - Obstetrics and Gynecology, Cardiovascular, Abdominal and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019 3
... Va., Aug. 30, 2011 Dilon expands its ... alliance with PenRad, rated #1 Mammography Information System ... innovation, high quality and customer loyalty are the ... provide leading-edge breast imaging tools, and an information ...
... announced the results of its Comprehensive Client Performance ... a 19 percent increase in their total revenue ... go-live. SuccessEHS believes this increase in revenue directly ... conjunction with the implementation of SuccessEHS software and ...
Cached Medicine Technology:Dilon Diagnostics® Partners With PenRad® 2Dilon Diagnostics® Partners With PenRad® 3SuccessEHS Solution Leads to 19 Percent Increase in Revenue 2SuccessEHS Solution Leads to 19 Percent Increase in Revenue 3
(Date:9/23/2014)... 2014 Mel Frank, also known as ... and harvesting marijuana. He is perhaps one of the ... he’ll be leading a special elective course on growing ... pm at Oaksterdam University in Oakland, California. ... nomenclature, harvesting and manicuring, and identifying preflowers and outdoor ...
(Date:9/23/2014)... September 23, 2014 Oaksterdam University has ... . In its first post, the University addresses the ... changing cannabis industry. , The cannabis industry is becoming ... is expecting an 18-month boost of more than $600 ... use pot sales. And, the new legal recreational marijuana ...
(Date:9/23/2014)... Mo. Infants, vocalizations throughout the first year ... and cooing to forming syllables and first words. ... amount of vocalizations may differ between hearing and ... that infant vocalizations are primarily motivated by infants, ... with profound hearing loss who received cochlear implants ...
(Date:9/23/2014)... 23, 2014 Florida Hospital Zephyrhills ... renovated Women’s Health Center on Wednesday, September 24. ... the specially designed center offers a new level ... County. The Women’s Health Center offers comprehensive women’s ... labor and delivery through The Baby Place®, and ...
(Date:9/23/2014)... 23, 2014 "The primary purpose of the ... an inventor from Sacramento, Ca.. "Call lights are often found ... hanging on the IV pole out of the patient's reach. ... call device whenever they need it, I created this caddy." ... the nurse call device within easy reach. The accessory ensures ...
Breaking Medicine News(10 mins):Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:Infant cooing, babbling linked to hearing ability, MU researcher finds 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3
... cancer when it works with,the growth-promoting protein IL-3 and ... Tenn., Nov. 27 A gene called N-Myc,leads a ... is overexpressed,helping to trigger acute myeloid leukemia (AML) under ... conditions, according to,results of a mouse study done by ...
... CHAPEL HILL, N.C., Nov. 27 A story ... "colleague spam" -- the habit of,co-workers indiscriminately hitting ... New research by benchmarking leader Best Practices, LLC,uncovered ... spam" -- the,tendency of organizations to send redundant ...
... Failing Marks for Second Straight Year, WASHINGTON, Nov. ... Report Card on Lung Cancer. This,Report is an assessment ... state of Georgia. LCA-GA is a chapter of Lung ... patient support and,advocacy for people living with or at ...
... Nov. 27 The Aesthetic Extender,Symposium announced its inaugural ... which will be held in Miami Beach,Florida on October ... the first,and only event of its kind. Unlike other ... its mission statement a goal of adhering to,the policies ...
... Nov. 27 A new, free white ... on choosing the,right electronics manufacturing services (EMS) ... to download at, http://www.federalelec.com/medicalpaper ., Medical ... consistent quality and,conformance to product and regulatory ...
... E.S.T. - Positron emission tomography (PET) is a useful ... staging of lung cancer and improved treatment for patients, ... Journal of National Cancer Institute. , The ... of Cancer Care Ontarios Program in Evidence-Based Care led ...
Cached Medicine News:Health News:St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia 2Health News:Using Efficient Communication to Boost Pharma Sales Force Productivity 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 3Health News:White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing 2Health News:PET imaging significantly enhances standard imaging in lung cancer staging 2
The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
Inquire...
... can be used for a variety of vacuum needs ... or volatile fumes., Quiet running operation ... changes forever , Chemically Resistant ... solvents such as acids and organics. ...
High-intensity 300-watt xenon lamp, with continuously adjustable output from 0 to 100% manually or automatically by camera video output signal....
Medicine Products: